SDG 3: Good Health & Well-Being | SDG 9: Industry, Innovation & Infrastructure
Institutions: Ministry of Science & Technology
On 03 October 2025, Dr. Jitendra Singh (Union Minister of State for Science & Technology, among other portfolios) highlighted India’s potential to advance affordable healthcare through indigenous medical technology (MedTech) during the inauguration of an exhibition on “Innovation for Self-Reliance – Accelerating Healthcare with Indigenous Medical Device Development.”
At SCTIMST (Sree Chitra Tirunal Institute for Medical Sciences & Technology), Thiruvananthapuram, innovations such as heart valves benefiting over 2 lakh patients, MRI-compatible shunts for ~2,000 patients, and a Hemostasis Patch for trauma care were showcased. These highlight how domestic R&D is producing solutions that can scale nationally.
India’s MedTech sector is valued at USD 12 billion, growing ~20 % annually, and projected to reach USD 50 billion by 2030. Dr. Singh stressed a model that combines Teaching, Training, Treatment and Trade, making SCTIMST not only a healthcare institute but also a driver of economic value.
Expanding indigenous MedTech aligns with Atmanirbhar Bharat and Make in India in health, reduces import dependence, and supports national schemes like Ayushman Bharat. Scaling these innovations could also position India in global medical exports.
What is MedTech? → “MedTech” refers to devices, equipment, and technologies developed for medical use-such as implants, diagnostic machines, prosthetics, or surgical tools. They matter because they improve access, lower costs, and enable domestic innovation.
Relevant Question for Policy Stakeholders: As domestic MedTech innovations expand, what regulatory and procurement frameworks are needed to ensure affordability, certification, and equitable access across states?
Follow the full news here: https://www.pib.gov.in/PressReleasePage.aspx?PRID=2174538